Literature DB >> 8503855

Synthesis of oligopeptide chloromethanes to investigate extended binding regions of proteinases: application to the interaction of fibrinogen with thrombin.

H Angliker1, E Shaw, S R Stone.   

Abstract

A method was established for the synthesis of oligopeptide chloromethanes which should be useful in the study of serine and cysteine proteinases with extended binding sites. The method involved condensation of an N-terminal peptide fragment obtained by solid-phase synthesis with a C-terminal peptide chloromethane synthesized by solution-phase chemistry. By using this procedure, oligopeptide chloromethanes of up to 16 residues were synthesized. These chloromethanes were based on the sequence of fibrinopeptide A. By using oligopeptide chloromethanes of different length, it was possible to show that the residues Asp7-Phe8-Leu9 play a crucial role in the recognition of fibrinopeptide A by thrombin. In contrast, the residues Ala1-Asp2-Ser3-Gly4-Glu5-Gly6 seem to play a minor role. Substitution of valine for Gly12, which occurs in a dysfibrinogenaemia, markedly decreased the rate of inactivation of thrombin by the oligopeptide chloromethane. The results are discussed in terms of the recently published structure of the complex between human thrombin and a chloromethane inhibitor based on fibrinopeptide A.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503855      PMCID: PMC1134298          DOI: 10.1042/bj2920261

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  The interaction of thrombin with fibrinogen. A structural basis for its specificity.

Authors:  M T Stubbs; H Oschkinat; I Mayr; R Huber; H Angliker; S R Stone; W Bode
Journal:  Eur J Biochem       Date:  1992-05-15

2.  The specificity of the fibrinogen-thrombin reaction.

Authors:  D H Hogg; B Blombäck
Journal:  Thromb Res       Date:  1974-11       Impact factor: 3.944

3.  Mechanism of action of thrombin on fibrinogen. Reaction of the N-terminal CNBr fragment from the Aalpha chain of human fibrinogen with bovine thrombin.

Authors:  T C Hageman; H A Scheraga
Journal:  Arch Biochem Biophys       Date:  1974-10       Impact factor: 4.013

4.  Mechanism of action of thrombin on fibrinogen. Size of the A alpha fibrinogen-like peptide that contacts the active site of thrombin.

Authors:  Y C Meinwald; R A Martinelli; J W van Nispen; H A Scheraga
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

5.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Covalent structure of fibrinogen.

Authors:  A Henschen; F Lottspeich; M Kehl; C Southan
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

7.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.

Authors:  P D Martin; W Robertson; D Turk; R Huber; W Bode; B F Edwards
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

8.  Mechanism of action of thrombin on fibrinogen. Direct evidence for the involvement of phenylalanine at position P9.

Authors:  H C Marsh; Y C Meinwald; S Lee; H A Scheraga
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

9.  Mechanism of action of thrombin on fibrinogen. Kinetic evidence for involvement of aspartic acid at position P10.

Authors:  H C Marsh; Y C Meinwald; T W Thannhauser; H A Scheraga
Journal:  Biochemistry       Date:  1983-08-30       Impact factor: 3.162

10.  Mechanistic studies on thrombin catalysis.

Authors:  S R Stone; A Betz; J Hofsteenge
Journal:  Biochemistry       Date:  1991-10-15       Impact factor: 3.162

View more
  3 in total

Review 1.  Endo/exo-proteolysis in neoplastic progression and metastasis.

Authors:  Abdel-Majid Khatib; Daniel Bassi; Geraldine Siegfried; Andres J P Klein-Szanto; L'Houcine Ouafik
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

2.  Allosteric modulation of the activity of thrombin.

Authors:  E J Duffy; H Angliker; B F Le Bonniec; S R Stone
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

Review 3.  Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Authors:  Yannick Bontemps; Nathalie Scamuffa; Fabien Calvo; Abdel-Majid Khatib
Journal:  Med Res Rev       Date:  2007-09       Impact factor: 12.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.